<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE316nnn/GSE316466/</Other></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Genomics</omics_type><species>Homo sapiens</species><gds_type>Genome binding/occupancy profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316466</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>ALKBH5 in Cancer-associated Fibroblasts Facilitates Pancreatic Cancer Metastasis via HSF1–LIF Axis [ATAC-seq]</name><description>Cancer-associated fibroblasts (CAFs) are principal determinants of pancreatic ductal adenocarcinoma (PDAC) progression, yet the epitranscriptomic mechanisms governing tumor–stroma crosstalk remain poorly understood. Here, we identify N6-methyladenosine (m6A) remodeling as a hallmark of CAF activation and define a critical role for the m6A demethylase AlkB homolog 5 (ALKBH5) in PDAC metastasis. Activated CAFs exhibit a global reduction in m6A abundance, with ALKBH5 emerging as a key regulator of the CAF epitranscriptome. Functionally, CAF-derived ALKBH5 enhances pancreatic cancer cell migration and invasion in vitro and promotes epithelial–mesenchymal transition–associated gene expression in tumor cells in an m6A-dependent manner. In vivo, orthotopic co-implantation models and host genetic ablation models demonstrate that ALKBH5 plays a critical role in metastatic dissemination, with minimal impact on primary tumor growth. Mechanistically, ALKBH5 enhances the m6A-dependent translation of heat shock factor 1 (HSF1) in CAFs, at least in part by relieving insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3)-associated translational constraints. Elevated HSF1 subsequently activates leukemia inhibitory factor (LIF) transcription through distal enhancer elements, establishing an ALKBH5–HSF1–LIF signaling axis that mediates pro-metastatic CAF–tumor cell communication. Clinically, enrichment of ALKBH5⁺/HSF1⁺ CAFs independently predicts poor prognosis and is preferentially observed in metastatic PDAC. Collectively, these findings uncover a CAF-intrinsic epitranscriptomic program that drives PDAC metastasis and highlight stromal m6A regulation as a potential therapeutic vulnerability.</description><dates><publication>2026/06/26</publication></dates><accession>GSE316466</accession><cross_references><GSM>GSM9453606</GSM><GSM>GSM9453607</GSM><GSM>GSM9453604</GSM><GSM>GSM9453605</GSM><GPL>24676</GPL><GSE>316466</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>